Insiders · Profile

Repella Robert

SVP & Chief Commercial Officer at Vanda Pharmaceuticals. Filing since 19 Nov 2013. CIK 0001532513

Company
Date
Role
Action
Shares
Amount
Of holding
21 Nov 2013
SVP & Chief Commercial Officer
Sold, plan not stated
64,100
$776.79K
81.0%
20 Nov 2013
SVP & Chief Commercial Officer
Sold, plan not stated
40,515
$481.66K
65.3%
19 Nov 2013
SVP & Chief Commercial Officer
Sold, plan not stated
2,885
$34.83K
11.8%
3 decisions on file.